Skip to Main Content

Paper Details

Minimal residual disease predicts outcomes in KMT2A-rearranged but not KMT2A-germline infant acute lymphoblastic leukemia: Report from Children's Oncology Group study AALL0631.
Pediatr Blood Cancer
0
2023
ALL, Children, KMT2A, KMT2A-rearranged, but not KMT2A-germline infant, acute lymphoblastic leukemia, infant, infants, lysine, patients
Author NameAffiliation
Meenakshi DevidasSt Jude Children's Research Hospital
Mignon L LohUniversity of Washington
Stephen P HungerDivision of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania
Stephen P HungerDivision of Oncology and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania
  • 1 - 4

Datasets

Release 1.2